- Home
- CFSB vs XFOR Comparison
CFSB vs XFOR Comparison
Compare CFSB & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- XFOR
- Stock Information
- Founded
- CFSB 1889
- XFOR 2014
- Country
- CFSB United States
- XFOR United States
- Employees
- CFSB N/A
- XFOR N/A
- Industry
- CFSB Major Banks
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CFSB Finance
- XFOR Health Care
- Exchange
- CFSB Nasdaq
- XFOR Nasdaq
- Market Cap
- CFSB 92.5M
- XFOR 84.3M
- IPO Year
- CFSB N/A
- XFOR N/A
- Fundamental
- Price
- CFSB $14.14
- XFOR $3.48
- Analyst Decision
- CFSB
- XFOR Strong Buy
- Analyst Count
- CFSB 0
- XFOR 3
- Target Price
- CFSB N/A
- XFOR $34.17
- AVG Volume (30 Days)
- CFSB 3.4K
- XFOR 425.2K
- Earning Date
- CFSB 10-28-2025
- XFOR 11-12-2025
- Dividend Yield
- CFSB N/A
- XFOR N/A
- EPS Growth
- CFSB N/A
- XFOR N/A
- EPS
- CFSB N/A
- XFOR N/A
- Revenue
- CFSB $7,612,000.00
- XFOR $32,774,000.00
- Revenue This Year
- CFSB N/A
- XFOR $1,307.51
- Revenue Next Year
- CFSB N/A
- XFOR N/A
- P/E Ratio
- CFSB N/A
- XFOR N/A
- Revenue Growth
- CFSB N/A
- XFOR 5721.31
- 52 Week Low
- CFSB $6.41
- XFOR $1.35
- 52 Week High
- CFSB $14.24
- XFOR $26.83
- Technical
- Relative Strength Index (RSI)
- CFSB 53.55
- XFOR 54.13
- Support Level
- CFSB $14.11
- XFOR $3.35
- Resistance Level
- CFSB $14.22
- XFOR $3.70
- Average True Range (ATR)
- CFSB 0.06
- XFOR 0.32
- MACD
- CFSB -0.01
- XFOR -0.01
- Stochastic Oscillator
- CFSB 62.50
- XFOR 71.43
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.